SOLTI Breast Cancer Research Group   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Barcelona Spain (1995)

Organization Overview

First Clinical Trial
2007
NCT00563953
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

SOLTI Breast Cancer Research Group